CD4 and neoplasm: Using mouse survival as the functional readout, Fig. 4C shows that although CTX + CD4 ACT significantly prolonged the lifespan of tumor-bearing mice as we reported previously25,26, the majority of mice (87%) in this cohort had late relapse and died by day 120.